Search research articles
Contact Us
Filters
Showing results (161-170 of 352) with videos related to
Page
of 36
Sort By:
Journal of Crohn'S & Colitis
|
March 13, 2012
Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease
Alessandro Armuzzi, Gert Van Assche, Walter Reinisch, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 22, 2003
Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-alpha production
Christoph Gasche, Paul Grundtner, Petra Zwirn, et al.
Therapeutic Advances in Gastroenterology
|
May 16, 2022
Corticosteroid-free efficacy and safety outcomes in patients receiving tofacitinib in the OCTAVE Sustain maintenance study
Stephan R Vavricka, Thomas Greuter, Benjamin L Cohen, et al.
Inflammatory Bowel Diseases
|
February 12, 2021
Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator Infliximab
Julián Panés, James O Lindsay, Niels Teich, et al.
The Journal of Rheumatology
|
November 16, 2021
Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study
Jeffrey R Curtis, Xiaofeng Zhou, David T Rubin, et al.
The American Journal of Gastroenterology
|
February 28, 2007
The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients
Brian G Feagan, Walter Reinisch, Paul Rutgeerts, et al.
Journal of Crohn'S & Colitis
|
June 13, 2024
Adaptive Steroid Tapering Impedes Corticosteroid-free Remissions Compared with Forced Tapering in Clinical Trials of Ulcerative Colitis
Neeraj Narula, Hasan Hamam, Jasmine Liu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
November 20, 2002
Prospective pilot study of recombinant granulocyte-macrophage colony-stimulating factor and interferon-gamma in patients with inoperable hepatocellular carcinoma
Walter Reinisch, Margareta Holub, Andreas Katz, et al.
Inflammatory Bowel Diseases
|
April 3, 2004
Infliximab: lack of efficacy on perforating complications in Crohn's disease
Wolfgang Miehsler, Walter Reinisch, Lili Kazemi-Shirazi, et al.
Journal of Crohn'S & Colitis
|
June 19, 2012
Tissue factor exposing microparticles in inflammatory bowel disease
Julia Palkovits, Gottfried Novacek, Marietta Kollars, et al.
Page
of 36
Search research articles
Search
Showing results (161-170 of 352) with videos related to
Sort By:
Page
of 36
Journal of Crohn'S & Colitis
|
March 13, 2012
Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease
Alessandro Armuzzi, Gert Van Assche, Walter Reinisch, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 22, 2003
Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-alpha production
Christoph Gasche, Paul Grundtner, Petra Zwirn, et al.
Therapeutic Advances in Gastroenterology
|
May 16, 2022
Corticosteroid-free efficacy and safety outcomes in patients receiving tofacitinib in the OCTAVE Sustain maintenance study
Stephan R Vavricka, Thomas Greuter, Benjamin L Cohen, et al.
Inflammatory Bowel Diseases
|
February 12, 2021
Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator Infliximab
Julián Panés, James O Lindsay, Niels Teich, et al.
The Journal of Rheumatology
|
November 16, 2021
Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study
Jeffrey R Curtis, Xiaofeng Zhou, David T Rubin, et al.
The American Journal of Gastroenterology
|
February 28, 2007
The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients
Brian G Feagan, Walter Reinisch, Paul Rutgeerts, et al.
Journal of Crohn'S & Colitis
|
June 13, 2024
Adaptive Steroid Tapering Impedes Corticosteroid-free Remissions Compared with Forced Tapering in Clinical Trials of Ulcerative Colitis
Neeraj Narula, Hasan Hamam, Jasmine Liu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
November 20, 2002
Prospective pilot study of recombinant granulocyte-macrophage colony-stimulating factor and interferon-gamma in patients with inoperable hepatocellular carcinoma
Walter Reinisch, Margareta Holub, Andreas Katz, et al.
Inflammatory Bowel Diseases
|
April 3, 2004
Infliximab: lack of efficacy on perforating complications in Crohn's disease
Wolfgang Miehsler, Walter Reinisch, Lili Kazemi-Shirazi, et al.
Journal of Crohn'S & Colitis
|
June 19, 2012
Tissue factor exposing microparticles in inflammatory bowel disease
Julia Palkovits, Gottfried Novacek, Marietta Kollars, et al.
Page
of 36